In a research note issued today, Canaccord analyst William Plovanic maintained a Buy rating on shares of MiMedx Group Inc (NASDAQ:MDXG), with a price target of …
Canaccord analyst William Plovanic weighed in today with an optimistic view on EnteroMedics Inc (NASDAQ:ETRM), following the company’s recent second-quarter results and a presentation at the …
In a research report published Tuesday, Canaccord Genuity analyst William Plovanic maintained a Buy rating on shares of EnteroMedics Inc (NASDAQ:ETRM), while reducing the …
Canaccord Genuity’s healthcare analyst William Plovanic weighed in with an optimistic view on EnteroMedics Inc (NASDAQ:ETRM), after the company provided an update regarding the training and …
In a research report released this morning, Canaccord Genuity analyst William Plovanic reiterated a Buy rating on EnteroMedics Inc (NASDAQ:ETRM) with a $4 price target, …
In a research report issued a short while ago, Canaccord Genuity analyst William Plovanic maintained a Buy rating on Enteromedics (NASDAQ:ETRM) with a …
In a research report issued today, Canaccord Genuity analyst William Plovanic maintained a Buy rating on Stryker Corp (NYSE:SYK) with a price target …